Category: Herbal Remedies

July 25, 2026

Spinocerebellar Ataxia

Abstract

Neurodegenerative inheritance is the hallmark of Spinocerebellar Ataxia Type 12 (SCA12), a condition that causes progressive coordination difficulties and differing levels of speech and movement. Although the genetic mutation is one-of-a-kind, its clinical course and symptom burden are determined by factors such as metabolic health, mitochondrial function (endocrine system function), oxidative stress levels, and cumulative environmental exposures. These interacting factors can make the condition particularly challenging for patients and families, as they may increase neuronal vulnerability and decrease functional reserve. In addition to describing the clinical features and contributing biological and lifestyle factors, the article also covers modern diagnostic techniques, including SCA12 in its current state, conventional management approaches, and integrative Ayurvedic support methods.

Spinocerebellar Ataxia

Introduction

SCA12 is classified as a spinocerebellar ataxia, which is primarily an inherited disorder that affects the cerebellum and its connections. SCA12 is distinguished by a significant upper-limb action tremor, which can lead to gait instability for several years, unlike other SACA subtypes. Progression can vary; some people may have a mild case and remain affected for several weeks, while others experience more extensive cerebellar and corticospinal symptoms. The genetic abnormality that underlies susceptibility, such as a CAG/CTG or CAB-repeat expansion in the pôleolytic factor receptor 2 (PPP2R2B) regulatory region, is established, but clinical manifestations are influenced by cellular energy status, chronic inflammation, exposure to toxic substances, and lifestyle factors that impact neuronal repair and resilience.

Causes and pathophysiology

Primary cause

Cerebral neurons and their circuits are affected by toxic gain-of-function or transcriptional dysregulation caused by the pôleolytic factor receptor 2 (PRP2R2) gene.

Biological mechanisms contributing to progression

  • Neurological loss and dysfunction in the cerebellar and brain structures.
  • Impaired integrity of the long-range motor pathways (with involvement of upper and lower motor neurons in later stages).
  • Tremor and dyscoordination were caused by a change in the homeostasis of the neurotransmitter and ion-channel.
  • The dysfunction of mitochondria and reduced ATP production in susceptible neurons.
  • Expendable protein folding, defective clearance (proteostasis imbalance), and chronic oxidative stress.

Common exacerbating factors (modifiable contributors)

  • Neuroplasticity and muscle support are diminished by sedentary behavior and the loss of neuromuscular conditioning.
  • Low intakes of antioxidants, essential fatty acids, B-vitamins and micronutrients also affect neuronal maintenance as well as myelin.
  • Chronic exposures such as tobacco, alcohol, pesticides, heavy metals and some occupational solvents increase the oxidative and inflammation burden on neural tissue.
  • Microvascular perfusion and neuronal metabolism are hampered by persistent metabolic dysfunction (insulin resistance, dyslipidemia) caused by systemic inflammation.
  • Insufficient sleep, chronic stress and dehydration slow down restorative processes and mitochondrial recovery.

Clinical presentation

  • An action-like tremor that is often felt in the hands, usually during writing, using utensils, or performing fine motions.
  • The development of gait instability, truncal ataxia, and involuntary limb movement.
  • Dysarthria (motor speech disorder which leads to slurred, slow, or otherwise impaired speech), mild changes in cognitive or mood and occasional sensory.
  • The gradual decline in fine motor abilities is influenced by the severity and rate of progression, with potential effects on daily life and occupational settings.

Diagnosis

  • A comprehensive medical and family history spanning three generations to identify autosomal dominant inheritance patterns and the origin of symptoms in different generations.
  • Assessment of neurology focusing on the classification of tremors (rest vs action), coordination testing (finger-nose, heel-shin), sensory processing analysis (gait), and auditory evaluation.
  • Brain MRI is employed to detect brain changes, cerebellar atrophy, and exclude structural mimics.
  • SCA panels that contain PPP2R2B (or the specific locus linked to SKA12) can be genetically tested for trinucleotide repeat expansions.
  • When there is suspicion of peripheral neuropathy or motor neurons, EMG and nerve conduction studies are utilized.
  • Testing in the laboratory for potential metabolic factors such as thyroid function, B12 levels, folate, glucose/HbA1c, liver and kidney function (and exposure to toxic substances when indicated)

Management approach

Principles

Multidisciplinary, targeted care based on symptom management combined with interventions that support cellular resilience and slow functional decline.
Manage treatment based on severity of symptoms, comorbidities and patient’s goals.

Conventional and supportive strategies

Symptomatic pharmacotherapy, such as specialist guidance for tremor-related medications, and follow-up on neurology.
The focus of physiotherapy is on maintaining balance and coordination, conditioning strength, and practicing specific tasks to prevent falls. This is done through training sessions.
To preserve independence, occupational therapy utilizes adaptive devices and fine-motor training.

Diagnosis and speech disorders

Positive care

Address manipulable medical causes– such as blood/skin glucose and lipid control, insulin deficiencies; sleep disorders; and systemic inflammation.

Limit occupational or environmental exposures and avoid neurotoxins (tobacco, excessive alcohol) to prevent disease progression.

Ayurvedic perspective

Pathogenic framework

The concept of neurological disorders in Ayurveda comes under the broad term of Vaatvyadhi. Kampavata, described within this spectrum, parallels modern tremor-predominant movement disorders such as SCA12:- classical descriptions of Vepathu (tremors) list Karapadatala Kampa (action tremors of hands and feet), Deha Bhramana (postural instability and gait disturbance), Nidrabhanga (sleep disruption), and Mati Ksheena (cognitive blunting), along with associated Stambha (rigidity), Cheshta Hani (slowness), Vinamana (stooped posture) and Vaak Vikriti (speech impairment). Ayurvedically, these signs are attributed to impairment and depletion of Majja Dhatu (nervous tissue) and Shukra (vital essence), together with vitiated and depleted Vata that disrupts neuromuscular coordination. Coexisting Ama (metabolic toxins) and low Agni (digestive/metabolic fire) prevent proper tissue nourishment and clearance, thereby accelerating degeneration, decreasing neural resilience, and producing the tremor-dominant, lower‑body sway and functional decline seen in SCA12—an integrative explanation that complements the genetic, mitochondrial, and inflammatory mechanisms recognized in contemporary medicine.

Principles of management

Correct Agni (metabolic fire), cast off Ama (endotoxins), balance irritated Vata and give Rasayana and Vajikarana to Majja and Shukra.

Treatments that combine Shodhana (purification) and Shamana (rehabilitation) to restore tissue health and balance in the system.

Prioritizing the regimen (dinacharya), nourishing diet, and lifestyle changes that safeguard Vata and promote neural health.

Classical herbs commonly utilized in supportive medical treatment

The adaptogenic and nervine tonic properties of Ashwagandha (Withania somnifera) contribute to muscle strength and stress relief.
Bala (Sida cordifolia), a native fruit, is traditionally used to treat muscle weakness and tremor.
Brahmi’s (Bacopa monnieri) plant may have cognitive-supportive and neuroprotective effects that could aid in coordination and neural recovery.
Using processed bitumen, shilajit is employed as an ojas- and mitochondrial-supporting rasayana to boost cellular energy, with the added benefit of ensuring the purity of all heavy metals.
The Guggulu formulas promote metabolic restitution, decrease inflammatory stiffness, and boost microcirculation.

Medicated oils, such as Brahmi Ghrita and Balashwagandha oil, are utilized for both deep tissue nourishment and external application to maintain muscle tone and neuromuscular stability. These substances can also be applied locally.

Practical tips and home-based strategies

  • Agni’s overall health is supported by consuming foods that are rich in antioxidants, B vitamins, and easily digestible food. These foods should also be berries, leafy greens or flaxseed since they contain omega-3 fatty acids.
  • Routine: Maintain a consistent sleep-wake cycle, moderate exercise, and food intake to promote circulation and neural development.
  • Perform daily exercises with a focus on balance and coordination, perform progressive resistance training for proximal strength, and practice fine motor skills such as writing and buttoning to maintain function.
  • By practicing pranayama, meditation, and gentle yoga techniques, stress can be managed by reducing Vata and supporting neuromuscular relaxation.
  • Safety measures include minimizing exposure to recognized neurotoxins, ensuring adequate ventilation in rooms, and wearing protective gear for work environments.
  • Sleep and hydration: Empty restorative sleep, enough fluids to flush out for metabolic breakdown.

Planet Ayurveda’s supportive formulations

Individually administered herbal support should be used with caution and under clinical guidance. The subsequent is the list of medicines that are most effective for this condition.-

  • Vrihat Vatchintamani Ras.
  • Neurogenie capsules.
  • Dashmularishta.
  • Brahmi Ghrit.
  • Triphala Guggul.
  • Balashwagandha oil.

Vrihat Vatchintamani Ras

Highly respected herbo-mineral formulation is recommended for severe nervous system challenges…. It includes refined noble minerals such as gold and silver calx (Bhasmas). Deep within the nerve tissues, these elements serve as potent cell-rejuvenators that enhance neural pathways and calm aggressive Vata while also managing ongoing shaking.

To achieve optimal results, one can consume one tablet twice a day with water or warm milk after meals. (Most commonly, the medication is recommended to be chewed after dipping in ghee.)

Neurogenie Capsules

This is the perfect nervine tonic, as it contains powerful Ashwagandha (Withinia somnifera) and Brahmi (Bacopa monnieri). A range of neuroprotective botanicals are combined by Neurogenie to combat free radical damage and neutralize inflammation. To maintain long-term nerve health, it contains bioactive ingredients that support mitochondrial energy, safeguard cell structures, and enhance communication across nerve synapses. Additionally.
Follow up with water, 1 capsule after meals, twice daily.

Dashmularisht

Using the roots of ten strong plants (Dashamula), a naturally fermented liquid tonic is created, which is reminiscent of classical drinks. By utilizing an organic herbal alcohol base, it can be quickly absorbed and penetrate deeply into the tissue. The remedy is frequently utilized to alleviate physical fatigue, soothe muscle soreness, enhance blood flow in the body, and reduce pain in nerves.
A 20 mL can be consumed with an equal amount of lukewarm water after meals, twice daily.

Brahmi Ghrit

Brahmi (Bacopa monnieri), the most potent and effective brain-strengthening herb in Ayurveda, is incorporated into this medicated clarified butter (ghee). Ghee’s ability to cross the blood-brain barrier allows it to function as an optimal delivery mechanism, directly feeding brain lipids and the myelin shields surrounding your nerves. This enhances coordination, cognitive resilience and speech clarity.
To take 1 teaspoon, one should drink warm milk or water on an empty stomach and eat it twice daily.

Triphala Guggul

Combining the detoxifying properties of Triphala and the anti-inflammatory properties, this tablet is a classic blend. Discarding metabolic waste, opening physical channels, and alleviating systemic inflammation that causes joint stiffness or nerve pain are the primary objectives of this treatment.
2 tablets taken with water twice daily after meals.

Balashwagandha Oil

Externally medicated oil combines Bala, a herb known for its strength-building properties in weak muscles, and Ashwagandha—a potent and deeply relaxing adaptogenic nerve tonic on. Applying this oil on the limbs and spine can soothe irritated peripheral nerves, improve muscle tone locally, and reduce the intensity of spasms.
Applying the dosage locally and then warming up the affected areas with a warm bath or utilizing ice packs.

Conclusion

Metabolic health, environmental exposures and lifestyle are all factors that affect the progression and burden of SCA12 – a genetic neurodegenerative disorder. Keeping function intact hinges on swift diagnosis, suitable neurological treatment, and rehabilitation. Ayurvedic treatments that prioritize digestion, detoxification, Vata pacification and targeted Rasayana therapy can provide supportive benefits when combined with conventional care. Quality products, clinical excellence, and personalized therapies are necessary. A combination of multidisciplinary care and optimal functional capacity optimization can result in reduced symptom burden and improved quality of life for many patients.

Continue Reading

July 23, 2026

Lipaglyn With Saroglitazar: Modern Therapeutic Approach To Diabetic Dyslipidemia And Its Ayurvedic Herbal Substitute

In the landscape of metabolic medicine, managing the overlap of high blood sugar and abnormal cholesterol levels has traditionally required a multi-drug cocktail. Patients with Type 2 Diabetes Mellitus frequently experience a specific, hazardous pattern of lipid disruption known as diabetic dyslipidemia. This condition is characterized by elevated triglycerides, high levels of low-density lipoprotein (LDL, or “bad” cholesterol), and dangerously low levels of high-density lipoprotein (HDL, or “good” cholesterol).

To address this complex, interconnected health challenge, researchers developed Lipaglyn, a prescription medication containing the novel active pharmaceutical ingredient Saroglitazar. Approved by regulatory authorities such as the Drug Controller General of India (DCGI), Lipaglyn represents a unique pharmacological class: it is a “first-in-class” dual peroxisome proliferator-activated receptor (PPAR) agonist.

Unlike older generations of metabolic medications that selectively target either glucose or fat metabolism, Lipaglyn addresses both pathways simultaneously. By acting as a unified therapeutic agent, it helps lower triglycerides, improves the overall lipid profile, and enhances glycemic control, significantly lowering the risk of long-term cardiovascular complications.

Mechanism of Action: The Power of Dual PPAR Activation

To appreciate how Lipaglyn achieves its dual therapeutic effects, it is necessary to examine the cellular receptors it targets. Saroglitazar works as a dual agonist at two specific sub-types of nuclear receptors: PPAR-alpha and PPAR-gamma. These receptors act as molecular switches that regulate the expression of genes involved in clearing fats and utilizing blood sugar.

PPAR-Alpha Activation: Fixing the Lipid Profile

he PPAR-alpha receptor is primarily active in the liver, skeletal muscle, and heart tissue, where it governs lipid oxidation and clearance. When Saroglitazar binds to and activates PPAR-alpha, it sets off a cascade of beneficial lipid-modifying events:

  • Enhanced Lipoprotein Lipase (LPL) Activity: It increases the activity of LPL, an enzyme responsible for breaking down circulating, triglyceride-rich particles like very-low-density lipoproteins (VLDL) and chylomicrons.
  • Reduced Triglyceride Synthesis: It suppresses the liver’s production of new triglycerides and inhibits the expression of Apolipoprotein C-III (Apo C-III), an element that normally slows down fat clearance.
  • Elevation of Good Cholesterol: It stimulates the production of Apolipoproteins A-I and A-II, which serve as the primary structural building blocks of HDL cholesterol, helping raise “good” cholesterol levels in the blood.

PPAR-Gamma Activation: Resolving Insulin Resistance

While PPAR-alpha handles fat clearance, the PPAR-gamma arm focuses on glucose utilization, primarily within adipose (fat) and muscle tissues. In individuals with Type 2 Diabetes, cellular responses to insulin are compromised, causing glucose to accumulate in the bloodstream. Saroglitazar’s activation of PPAR-gamma corrects this by:

  • Sensitizing Peripheral Tissues: It alters gene expression to make muscle and fat cells highly sensitive to insulin, allowing them to absorb glucose from the blood efficiently.
  • Stimulating Adiponectin: It increases the secretion of adiponectin, an adipose-derived hormone that improves glucose regulation and limits tissue inflammation.
  • Lowering Glycated Hemoglobin (HbA1c): By lowering fasting plasma glucose levels, it directly aids in reducing HbA1c levels, providing smoother, long-term blood sugar control.

Therapeutic Indications and Clinical Efficacy

Lipaglyn is primarily prescribed to manage metabolic conditions where glucose and lipid imbalances occur together. Its clinical utility extends across several key areas:

Diabetic Dyslipidemia and Hypertriglyceridemia

The primary indication for Lipaglyn is the management of elevated triglycerides and mixed dyslipidemia in patients with Type 2 Diabetes. Clinical trials, including the EVIDENCES study series, demonstrate that a standard daily dose of 4 mg significantly reduces serum triglycerides (often by 45% or more) while lowering non-HDL cholesterol and raising beneficial HDL levels.

Non-Alcoholic Fatty Liver Disease (NAFLD) and NASH

Because fat metabolism is intimately tied to liver health, excess circulating triglycerides often accumulate within liver cells, causing Non-Alcoholic Fatty Liver Disease (NAFLD). If left unchecked, this progresses to Non-Alcoholic Steatohepatitis (NASH), marked by liver inflammation and scarring (fibrosis).

Saroglitazar has shown excellent results in reducing hepatic fat fraction, lowering elevated liver enzymes like Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST), and mitigating liver stiffness and ballooning degeneration in biopsy-proven NASH trials.

Safety Profile, Side Effects, and Advantages

One of the most notable features of Lipaglyn is its favorable tolerability profile, especially when compared to historical PPAR agonists (such as glitazones or fibrates).

Common, Mild Side Effects

While Lipaglyn is generally well-tolerated, some patients may experience mild side effects, which typically resolve as the body adapts to the medication:

  • Gastrointestinal Symptoms: Mild gastritis, nausea, dyspepsia, or a feeling of stomach inflammation.
  • Systemic Manifestations: Occasional mild headaches, dizziness, or localized fatigue (asthenia).
  • Pyrexia: Infrequent, low-grade fever during the initial phases of therapy.

Key Advantages Over Older Drug Classes

Older medications that target PPAR receptors often carry heavy side-effect burdens. For example, older insulin sensitizers frequently cause significant fluid retention, peripheral edema (swelling), congestive heart failure risks, and notable weight gain. Fibrates, on the other hand, can sometimes trigger muscle pain (myopathy) or stress the kidneys.

Saroglitazar’s unique molecular structure allows it to achieve high therapeutic potency with minimal side effects:

  • No Significant Weight Gain: Clinical evaluations show no notable increase in body weight or abnormal fat accumulation.
  • No Edema or Fluid Retention: It does not cause the dangerous fluid retention often seen with older PPAR-gamma agents.
  • Non-Renal Elimination: Because it is not primarily cleared through the kidneys, it presents a lower risk of renal strain, making it an option doctors consider carefully for patients with delicate metabolic profiles.

The Ayurvedic Perspective: Metabolic Dysregulation as Prameha and Medoroga

To find an effective alternative or supportive herbal therapy within Ayurveda, we must translate the modern medical concepts of diabetic dyslipidemia and fatty liver into classical Ayurvedic principles.

In Ayurveda, Type 2 Diabetes is categorized under Prameha (specifically Madhumeha), a disease primarily rooted in an imbalance of the Kapha Dosha and an impairment of the body’s metabolic fire, known as Agni.

When Agni becomes sluggish (Mandagni), the body cannot digest food components completely. This results in the formation of Ama—a toxic, sticky, undigested metabolic byproduct. In diabetic dyslipidemia, this Ama mixes with disrupted fat tissue (Medo Dhatu), leading to a state called Medoroga (metabolic lipid disorders) and Srotorodha (the micro-channels of the body becoming clogged with sticky fat and metabolic waste).

To match the dual-action power of Lipaglyn, an Ayurvedic remedy must be able to rekindle Agni, eliminate deep-seated Ama, digest excess fat, and clear the body’s channels.

The Ideal Ayurvedic Herbal Substitute: Musta (Cyperus rotundus)

While several herbs support metabolic health, clinical research and traditional texts point to Musta (known botanically as Cyperus rotundus, and commonly referred to as Nut Grass) as a premier herbal counterpart for addressing the specific challenges of dyslipidemia and metabolic imbalance.

In comparative clinical meta-evaluations of various Ayurvedic interventions for dyslipidemia, formulations containing Musta Churna (the fine root powder of the herb) consistently demonstrate exceptional efficacy. Research indicates it can help reduce total cholesterol, lower serum triglycerides significantly, reduce bad LDL cholesterol, and simultaneously support a healthy rise in good HDL cholesterol. This broad-spectrum lipid-modifying impact mirrors the dual-action profile of modern PPAR agonists.

How Musta Works: Mechanisms of Action in Ayurveda and Modern Science

Musta targets metabolic disorders through a multi-faceted approach, combining traditional energetic principles with validated pharmacological pathways.

Energetic Properties (Rasa, Virya, Vipaka)

Musta possesses an optimal combination of Ayurvedic attributes that allow it to counter the root causes of Prameha and Medoroga

  • Katu, Tikta, Kashaya Rasa (Pungent, Bitter, and Astringent Tastes): These tastes directly counter the heavy, sticky, sweet qualities of excess Kapha and accumulated fat (Medas).
  • Laghu and Ruksha Guna (Light and Dry Qualities): These properties physically scrap away excess fat accumulation and dry up damp, sluggish metabolic wastes.
  • Sheeta Virya (Cooling Potency) & Katu Vipaka (Pungent Post-Digestive Effect): This unique balance ensures that while the herb strongly stimulates metabolism and digests fats, it does not aggravate systemic inflammation or overheat the body.

Deepana and Pachana (Rekindling Fire and Digesting Toxins)

The primary way Musta corrects blood lipid and glucose abnormalities is through its potent Deepana (appetite-stimulating) and Pachana (toxin-digesting) actions. It acts directly on the liver (Yakrit) and the localized tissue metabolic fires (Dhatvagni). By clearing the sticky Ama that coats insulin receptors, Musta helps restore natural cellular sensitivity, allowing the body to process sugars and fats efficiently without creating toxic accumulations.

Lekhana Karma (Scrapping of Excess Tissue Fats)

In classical Ayurveda, Musta is celebrated for its Lekhana or “scrapping” action. Just as Lipaglyn activates PPAR-alpha to clear circulating VLDL and triglycerides from the blood, Musta physically and metabolically scraps away excess fat accumulation from the blood vessels and liver cells, helping reverse conditions like fatty liver disease (NAFLD).

Modern Pharmacological Correlates

Modern phytochemical analyses reveal that Musta is rich in active essential oils, flavonoids, terpenoids, and polyphenols. These natural plant compounds exhibit strong antioxidant and anti-inflammatory properties that protect blood vessels from cholesterol-induced damage.

Furthermore, research indicates that Musta extracts modulate key enzymes involved in carbohydrate and fat metabolism, gently encouraging the liver to burn fatty acids rather than storing them, while helping keep blood sugar readings stable.

Practical Application and Integration

While Musta presents an excellent natural approach to metabolic care, managing conditions like diabetes and dyslipidemia requires a careful, personalized strategy.

Sourcing and Dosages

Musta is traditionally consumed as a fine root powder (Musta Churna) at a standard dose of 2 to 3 grams, taken twice daily with warm water, typically before meals. It can also be prepared as a concentrated decoction (Kwath).

Important Clinical Considerations

It is critical to recognize that herbal alternatives should never be substituted abruptly for prescribed medications like Lipaglyn without close medical supervision. Lipaglyn is a high-potency, targeted pharmaceutical agent designed for acute or deep-seated metabolic crises.

An herbal substitute like Musta works beautifully as part of a long-term, preventative approach or alongside modern therapies to help reduce dependence on multiple medications over time. Any adjustments to your treatment plan must be made in consultation with your prescribing physician and a qualified Ayurvedic doctor to ensure your blood sugar and lipid levels remain safely controlled.

Continue Reading

Click the CROSS button to close